B

BeOne

Global oncology therapeutics discovery, development, manufacturing

Senior Manager - Global Value, Access & Pricing, Hematology

Growth & MarketingConfirmed live in the last 24 hours
Full-timeBasel, SwitzerlandCHF164k - CHF205k

About the Job

Requirements

  • A bachelor's degree in life sciences, health economics, pharmacy, health policy, business, or a related field is required; an advanced degree (MSc, MPH, PharmD, PhD, or MBA) is strongly preferred.
  • At least 7 years of biopharmaceutical experience, with a substantial portion in global or major-market value, access, pricing, and reimbursement roles.
  • Demonstrated experience developing global pricing and market access strategy for specialty or oncology/hematology products, ideally including launch readiness.
  • Working knowledge of HTA processes and payer systems across key markets, including EU JCA, G-BA/IQWiG, NICE, HAS, and the US payer environment.
  • Experience building global value dossiers, HTA submission content, and payer value evidence in partnership with HEOR.
  • Strong understanding of pivotal-trial evidence interpretation and comparator/competitive assessment in oncology or hematology.
  • Proven ability to lead cross-functional and cross-regional initiatives and influence without direct authority in a matrixed, global organization.
  • Excellent written and verbal communication skills in English.

Responsibilities

  • Support the development of global pricing and reimbursement strategy across therapeutic areas and indications, aligned to pivotal evidence and relevant comparators.
  • Support collection and aggregation of feedback from all regions and develop recommendations for clinical development evidence-generation needs.
  • Translate regional and affiliate payer insights into actionable recommendations for clinical development, evidence generation, access strategy, pricing considerations, and commercialization planning.
  • Partner with Pricing, HEOR, Medical Affairs, Regulatory Affairs, Commercial, Clinical Development, and regional access teams to align global access and pricing tactics across the asset lifecycle.
  • Provide input into asset lifecycle planning, indication sequencing, and evidence prioritization, and contribute to governance and oversight bodies as delegated.
  • Collaborate cross-functionally to integrate access requirements into the development process, influencing trial design, endpoints, and evidence generation to meet payer needs.
  • Develop early value propositions that resonate with global payers and support future pricing, reimbursement, and access decisions.
  • Identify and prioritize payer evidence gaps and other data needs to address payer concerns and enhance product differentiation in the indication or therapeutic area.
  • Coordinate with Clinical Development, Regulatory, HEOR, Medical Affairs, Commercial, and regional/country access teams to incorporate access needs into integrated evidence plans.
  • Provide input into asset lifecycle planning, indication sequencing, and evidence prioritization to maximize long-term access, reimbursement, and portfolio value.
  • Build country-ready reimbursement toolkits in collaboration with HEOR, including global value dossiers, budget-impact and cost-effectiveness frameworks, and payer communication materials aligned to pivotal evidence and comparators.
  • Lead Joint Clinical Assessment dossier development in collaboration with HEOR, GVAP JCA coordinators, and the wider cross-functional team.
  • Drive global launch and access readiness activities, sequencing milestones, evidence needs, and access deliverables to support first and subsequent indication launches.
  • Provide ongoing communication, training, and support to regional and affiliate teams to prepare them to engage effectively with payers as the product nears market entry.
  • Monitor the relevant therapeutic-area competitive, pricing, and policy landscape, translating changes into actionable updates to strategy and toolkits.

Desired Qualifications

  • Experience working within a country, regional, or affiliate market access, reimbursement, pricing, or HTA function, with direct exposure to payer decision-making and reimbursement processes.

About the Company

BeOne

Global oncology therapeutics discovery, development, manufacturing

BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dongcheng District, China
Founded
2010

Recently Posted Jobs

Explore more opportunities at BeOne

See more jobs